US 11,986,302 B2
Urine collection systems and associated methods and devices
Eric Conley, York, ME (US); Andrew Victor Halpert, Brookline, MA (US); Kenneth John Luppi, Tewksbury, MA (US); and Antony Jonathan Fields, San Francisco, CA (US)
Assigned to Reprieve Cardiovascular, Inc., Milford, MA (US)
Filed by REPRIEVE CARDIOVASCULAR, INC., Milford, MA (US)
Filed on Mar. 30, 2023, as Appl. No. 18/193,508.
Application 18/193,508 is a continuation of application No. 17/805,897, filed on Jun. 8, 2022, granted, now 11,633,137.
Application 17/805,897 is a continuation of application No. 17/659,393, filed on Apr. 15, 2022.
Claims priority of provisional application 63/220,873, filed on Jul. 12, 2021.
Claims priority of provisional application 63/175,380, filed on Apr. 15, 2021.
Prior Publication US 2023/0233124 A1, Jul. 27, 2023
Int. Cl. A61B 5/20 (2006.01); A61F 5/44 (2006.01); A61M 1/00 (2006.01)
CPC A61B 5/208 (2013.01) [A61F 5/4405 (2013.01); A61M 1/74 (2021.05); A61M 1/80 (2021.05); A61M 2205/3396 (2013.01); A61M 2230/005 (2013.01)] 19 Claims
OG exemplary drawing
 
1. A fluid therapy system, comprising:
a urine collection device;
a fluid line configured to direct urine flow from a patient to the urine collection device; and
a urine measurement device including a first sensor configured to generate first sensor data based on an amount of urine in the urine collection device, and a second sensor configured to generate second sensor data based on urine flow from the patient to the urine collection device; and
a urine cartridge,
wherein the second sensor and the urine cartridge together define opposing sides of a channel that directly receives a portion of the fluid line between the opposing sides, and
wherein the second sensor immobilizes the portion of the fluid line.